The present invention relates to novel antiobesity and hypocholesterolemic
compounds, their derivatives, their analogs, their tautomeric forms, their
stereoisomers, their polymorphs, their pharmaceutically acceptable salts,
their pharmaceutically acceptable solvates and pharmaceutically acceptable
compositions containing them. More particularly, the present invention
relates to novel .beta.-aryl-.alpha.-oxysubstituted alkylcarboxylic acids
of the general formula (I), their derivatives, their analogs, their
tautomeric forms, their stereosomers, their polymorphs, their
pharmaceutically acceptable salts, their pharmaceutically acceptable
solvates and pharmaceutically acceptable compositions containing them.
##STR1##
The present invention also relates to a process for the preparation of the
above said novel compounds, their analogs, their derivatives, their
tautomeric forms, their stereoisomers, their polymorphs, their
pharmaceutically acceptable salts, pharmaceutically acceptable solvates,
novel intermediates and pharmaceutical compositions containing them.
La présente invention concerne l'antiobesity de roman et les composés hypocholestérolémiques, leurs dérivés, leurs analogues, leurs formes tautomeric, leurs stéréoisomères, leurs polymorphes, leurs sels pharmaceutiquement acceptables, leurs solvates pharmaceutiquement acceptables et pharmaceutiquement les compositions acceptables les contenant. Plus en particulier, la présente invention concerne les acides alkylcarboxylic d'beta.-aryle-.alpha.-oxysubstituted de roman de la formule générale (i), de leurs dérivés, de leurs analogues, de leurs formes tautomeric, de leurs stereosomers, de leurs polymorphes, de leurs sels pharmaceutiquement acceptables, de leurs solvates pharmaceutiquement acceptables et pharmaceutiquement de compositions acceptables les contenant. ## du ## STR1 La présente invention se relie également à un procédé pour la préparation des composés ci-dessus de roman, de leurs analogues, de leurs dérivés, de leurs formes tautomeric, de leurs stéréoisomères, de leurs polymorphes, de leurs sels pharmaceutiquement acceptables, pharmaceutiquement de solvates acceptables, d'intermédiaires de roman et de compositions pharmaceutiques les contenant.
